Skip to main content
Log in

Glycine and D-serine decrease MK-801-induced hyperactivity in mice

  • Basic Neurosciences and Genetics
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

It is well known that the un-competitive N-methyl-D-aspartate (NMDA) receptor antagonist phencyclidine can induce a syndrome in humans that mimics both positive and negative symptoms of schizophrenia. In the light of this observation, it has been hypothesised that schizophrenia might be due to a hypofunction of central glutamate systems. A glycine agonist, by strengthening glutamatergic transmission, has been suggested to be useful as treatment. A crucial issue is the uncertainty regarding the degree of saturation of the glycine site associated with the NMDA receptor. The purpose of this study was to investigate if it is possible to strengthen NMDA receptor-mediated neurotransmission by modulating the associated glycine site. The effects of systemic and intraventricular administration of glycine, D-serine and L-serine on the hyperactivity induced in mice by the uncompetitive NMDA receptor antagonist MK-801 were tested. Systemically administered glycine and D-serine were found to decrease MK-801-induced hyperactivity. Intraventricularly administered D-serine in doses of 50 or 100μg/side was found to decrease MK-801-induced hyperactivity during the second half hour of registration; L-serine given in the same doses did not affect the MK-801-induced hyperactivity during this period. These data may suggest that the NMDA receptor-associated glycine site is not saturated in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bristow DR, Bowery NG, Woodruff GN (1986) Light microscopic autoradiographic localisation of [3H]glycine and [3H]strychnine binding sites in rat brain. Eur J Pharmacol 126: 303–307

    Google Scholar 

  • Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1: 179–186

    Google Scholar 

  • Carlsson A (1992) Neurotransmitter dysfunction in schizophrenia. Proceedings, 7th International Symposium of the Tokyo Institute of Psychiatry, October 19–20 Tokyo, Japan, pp 167–183

  • Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia — implications for schizophrenia and Parkinson's disease. TINS 13: 272–276

    Google Scholar 

  • Chouinard ML, Gaitan D, Wood PL (1993) Presence of the N-methyl-d-aspartate-associated glycine receptor agonist, d-serine, in human temporal cortex: comparison of normal, Parkinson, and Alzheimer tissues. J Neurochem 61: 1561–1564

    Google Scholar 

  • Contreras PC (1990) D-serine antagonized phencyclidine- and MK-801-induced stereotyped behaviour and ataxia. Neuropharmacology 29: 291–293

    Google Scholar 

  • Cuzick J (1985) A Wilcoxon-type test for trend. Stat Med 4: 87–90

    Google Scholar 

  • Garland Bunney B, Bunney WE Jr, Carlsson A (1995) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1205–1214

    Google Scholar 

  • Hashimoto A, Oka T, Nishikawa T (1995) Extracellular concentration of endogenous free d-serine in the rat brain as revealed by in vivo microdialysis. Neurosci 66: 635–643

    Google Scholar 

  • Javitt DC (1987) Negative schizophrenic symptomatology and PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psych 9: 12–33

    Google Scholar 

  • Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20: 379–382

    Google Scholar 

  • Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9–19

    Google Scholar 

  • Lehmann J, Colpaert F, Canton H (1991) Clutamate and glycine co-activate while polyamines merely modulate the NMDA receptor complex. Prog Neuropsychopharmacol Biol Psychiatry 15: 183–190

    Google Scholar 

  • Lodge D, Johnson KM (1990) Noncompetitive excitatory amino acid receptor antagonists. TIPS 11: 81–86

    Google Scholar 

  • MacDonald JF, Nowak LM (1990) Mechanisms of blockade of excitatory amino acid receptor channels. TIPS 11: 167–172

    Google Scholar 

  • McBain CJ, Kleckner NW, Wyrick S, Dingledine R (1989) Structural requirements for activation of the glycine coagonist site of N-methyl-D-aspartate receptors expressed in xenopus oocytes. Mol Pharmacol 36: 556–565

    Google Scholar 

  • McDonald JW, Penney JB, Johnston MV, Young AB (1990) Characterization and regional distribution of strychnine-insensitive [3H]glycine binding sites in rat brain by quantitative receptor autoradiography. Neurosci 35: 653–668

    Google Scholar 

  • Nilsson M, Carlsson ML (1997) The glycine antagonist (+)-HA-966 injected into the nucleus accumbens stimulates locomotion in mice. J Neural Transm 104: 419–425

    Google Scholar 

  • Patel J, Zinkand WC, Thompson C, Keith R, Salama A (1990) Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity. J Neurochem 54: 849–854

    Google Scholar 

  • Pullan LM, Powel RJ (1992) Comparison of binding at strychnine-sensitive (inhibitory glycine receptor) and strychnine-insensitive (N-methyl-D-aspartate receptor) glycine binding sites. Neurosci Lett 148: 199–201

    Google Scholar 

  • Rao TS, Cler JA, Emmett MR, Mick SJ (1990) Glycine, glycinamide and D-serine act as positive modulators of signal transduction at the N-methyl-D-aspartate (NMDA) receptor in vivo: differential effects on mouse cerebellar cyclic guanosine monophosphate levels. Neuropharmacology 29: 1075–1080

    Google Scholar 

  • Reynolds IJ, Miller RJ (1988) Multiple sites for the regulation of the N-methyl-D-aspartate receptor. Mol Pharmacol 33: 581–584

    Google Scholar 

  • Salt TE (1989) Modulation of NMDA receptor-mediated responses by glycine and dserine in the rat thalamus in vivo. Brain Res 481: 403–406

    Google Scholar 

  • Schell MJ, Molliver ME, Snyder SH (1995) D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 92: 3948–3952

    Google Scholar 

  • Singh L, Oles RJ, Tricklebank MD (1990) Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex. Br J Pharmacol 99: 285–288

    Google Scholar 

  • Tanii Y, Nishikawa T, Hashimoto A, Takahashi K (1994) Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J Pharmacol Exp Ther 269: 1040–1048

    Google Scholar 

  • Thomson AM (1990) Glycine is a coagonist at the NMDA receptor/channel complex. Prog Neurobiol 35: 53–74

    Google Scholar 

  • Toth E, Lajtha A (1986) Antagonism of phencyclidine-induced hyperactivity by glycine in mice. Neurochem Res 11: 393–400

    Google Scholar 

  • White WF, Brown KL, Frank DM (1989) Glycine binding to rat cortex and spinal cord: binding characteristics and pharmacology reveal distinct populations of sites. J Neurochem 53: 503–512

    Google Scholar 

  • Wong EHF, Kemp JA (1991) Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. Ann Rev Pharmacol Toxicol 31: 401–425

    Google Scholar 

  • Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83: 7104–7108

    Google Scholar 

  • Wood PL (1995) The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo? Life Sci 57: 301–310

    Google Scholar 

  • Wood PL, Emmett MR, Rao TS, Micks S, Cler J, Lyengar S (1989) In vivo modulation of the NMDA receptor complex by d-serine. Potentiation of on-going neuronal activity as evidenced by increased cerebellar cGMP. J Neurochem 53: 979–981

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nilsson, M., Carlsson, A. & Carlsson, M.L. Glycine and D-serine decrease MK-801-induced hyperactivity in mice. J. Neural Transmission 104, 1195–1205 (1997). https://doi.org/10.1007/BF01294720

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01294720

Keywords

Navigation